Cargando…

Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).

There have been conflicting data about the interactions between vancomycin and beta-lactam agents against Staphylococcus aureus strains with heterogeneous resistance to vancomycin. We evaluated the efficacy of these combinations against Mu 3 and heterogeneously vancomycin-resistant S. aureus (hetero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yeon Sook, Kiem, Sungmin, Yun, Hwan-Jung, Jung, Sook In, Oh, Won Sup, Kim, Shin-Woo, Peck, Kyong Ran, Lee, Nam Yong, Song, Jae-Hoon
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Academy of Medical Sciences 2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055038/ https://www.ncbi.nlm.nih.gov/pubmed/12808315

Ejemplares similares

Synergy of Arbekacin-based Combinations Against Vancomycin Hetero-intermediate Staphylococcus aureus
por: Lee, Ji-Young, et al.
Publicado: (2006)

271 Detection, evolution and outcome of the first case of Vancomycin Resistant Staphylococcus aureus (VRSA) infection in Europe
por: Melo-Cristino, Jose, et al.
Publicado: (2014)

Prevalence of vancomycin resistant Staphylococcus aureus (VRSA) in methicillin resistant S. aureus (MRSA) strains isolated from burn wound infections
por: Hasan, Rashedul, et al.
Publicado: (2016)

Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India
por: Tiwari, Hare Krishna, et al.
Publicado: (2006)

Vancomycin (VAN) Combinations with Β-Lactams (BLs) against Methicillin-Resistant Staphylococcus aureus (MRSA), Heterogeneous Intermediate-Level Resistance to Vancomycin (hVISA) and Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Tran, Kieu-Nhi, et al.
Publicado: (2017)

Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
por: Park, Jung Wan, et al.
Publicado: (2019)

Amelioratory Effect of Nanoconjugated Vancomycin on Spleen during VRSA-Induced Oxidative Stress
por: Chakraborty, Subhankari Prasad, et al.
Publicado: (2011)

A case report of postoperative VRSA enteritis: Effective management of rifampicin for vancomycin resistant Staphylococcus aureus enteritis after esophagectomy and colon reconstruction
por: Okada, Naoya, et al.
Publicado: (2018)

Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus
por: Ramaraj, Thiruvarangan, et al.
Publicado: (2014)

Antibiofilm Effect of Octenidine Hydrochloride on Staphylococcus aureus, MRSA and VRSA
por: Amalaradjou, Mary Anne Roshni, et al.
Publicado: (2014)

Vancomycin Resistance in Staphylococcus aureus 
por: McGuinness, Will A., et al.
Publicado: (2017)

Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
por: Zhang, Shanshan, et al.
Publicado: (2015)

Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus
por: Hu, Qiwen, et al.
Publicado: (2016)

Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
por: Liang, Jin, et al.
Publicado: (2023)

Reduced Susceptibility to Vancomycin in Staphylococcus aureus
por: Mimica, Marcelo J.
Publicado: (2011)

Evaluating vancomycin susceptibility in Staphylococcus aureus
por: Mimica, Marcelo J, et al.
Publicado: (2016)

Determination of Vancomycin-resistant Staphylococcus aureus
por: Ghasabi, Farzane, et al.
Publicado: (2017)

Vancomycin Resistance in Enterococcus and Staphylococcus aureus
por: Li, Gen, et al.
Publicado: (2022)

Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis
por: Shariati, Aref, et al.
Publicado: (2020)

Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: a 14-year retrospective study
por: Kang, Yu Ri, et al.
Publicado: (2022)

Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
por: Peng, Huagang, et al.
Publicado: (2018)

Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus
por: Katayama, Yuki, et al.
Publicado: (2016)

Cell wall thickness and the molecular mechanism of heterogeneous vancomycin‐intermediate Staphylococcus aureus
por: Cui, J., et al.
Publicado: (2021)

Vancomycin Activates σ(B) in Vancomycin-Resistant Staphylococcus aureus Resulting in the Enhancement of Cytotoxicity
por: Chen, Hong-Yi, et al.
Publicado: (2011)

Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
por: Lin, Lee-Chung, et al.
Publicado: (2018)

Report of β-lactam antibiotic–induced vancomycin-resistant Staphylococcus aureus from a university hospital in Egypt
por: Taha, A.E., et al.
Publicado: (2019)

Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients
por: Koh, Young Rae, et al.
Publicado: (2016)

Successful Treatment of Vancomycin-Resistant Enterococcus species Bone and Joint Infection with Daptomycin Plus Beta Lactam Agents
por: La, Yeon Ju, et al.
Publicado: (2022)

1066. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does β-Lactam class Matter?
por: Dilworth, Thomas J, et al.
Publicado: (2018)

Draft Genome Sequences of Vancomycin-Intermediate Staphylococcus aureus Strains in South Korea
por: Kim, Jung Wook, et al.
Publicado: (2016)

Draft Genomes of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strain MM66 and MM66 Derivatives with Altered Vancomycin Resistance Levels
por: Matyi, Stephanie A., et al.
Publicado: (2014)

Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA
por: Lai, Chih-Cheng, et al.
Publicado: (2017)

Vancomycin Tolerant, Methicillin-Resistant Staphylococcus aureus Reveals the Effects of Vancomycin on Cell Wall Thickening
por: Cázares-Domínguez, Vicenta, et al.
Publicado: (2015)

Novel vancomycin–peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus
por: Jelinkova, Pavlina, et al.
Publicado: (2018)

Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive Staphylococcus aureus Strains
por: Jin, Ye, et al.
Publicado: (2020)

MIC and MBC of Honey and Gold Nanoparticles against methicillin-resistant (MRSA) and vancomycin-resistant (VRSA) coagulase-positive S. aureus isolated from contagious bovine clinical mastitis
por: Omara, Shimaa T.
Publicado: (2017)

162. Assessment of Beta-lactam Allergies as Rationale for Receipt of Vancomycin for Surgical Prophylaxis
por: Tucker, Kendall J, et al.
Publicado: (2020)

Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia
por: Wong, Davie, et al.
Publicado: (2016)

Vancomycin-Resistant Staphylococcus aureus, Michigan, USA, 2007
por: Finks, Jennie, et al.
Publicado: (2009)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_t042n2j5sornuoio6hshk8p3o0